Tag Archives: New York

New York State

New York Gov. Cuomo Proposes Physicians Pay for State’s Excess Coverage

New York Gov. Andrew Cuomo unveiled his 2022 State Budget proposal last month, which included a restructuring of the state’s excess medical liability program for physicians.

Under Section 18 of the New York Medical Malpractice Reform Act, physicians who maintain primary insurance coverage limits of $1.3 million per claim and $3.9 million in annual aggregate with a New York State-admitted medical liability insurance company are eligible — at no cost — for an additional $1 million per claim and $3 million in annual aggregate coverage from the state’s excess medical liability insurance program. Access to the free program has been a competitive advantage that medical professional liability insurance companies operating in the state’s standard admitted market have had over risk retention groups and other alternative risk transfer products.

New York is facing a two-year, $15 billion budget deficit, and Gov. Cuomo’s proposed budget would save the state about $51 million annually by requiring physicians with access to the excess medical liability program to cover half of the coverage costs. The governor’s Fiscal Year 2022 Executive Budget Briefing Book cites a stabilized, strengthened medical malpractice insurance market since the excess fund’s creation and a 24% decrease in enrollment since 2015 as justifications for the restructuring.

“This [budget proposal] is both ill timed and shortsighted,” wrote Bonnie Litvack, MD, president of the Medical Society of the State of New York (MSSNY), in a January 21 communication with members posted on the society’s website. “Physician practices in the pandemic have been struggling to keep the doors open.  If imposed, this will be the final straw for many practices and additional patients will lose access to care at a time when they and their communities need their physicians most.

“The excess program exists in the first place due to New York’s dysfunctional medical malpractice adjudication system (the worst in the country) and is akin to treating cancer with pain medications only. It is time to use tried and true remedies, like caps on pain and suffering [damages], expert witness reform and certificate of merit reform.”

In related news, Gov. Cuomo recently pledged to modernize the Department of Health’s Office of Professional Medical Conduct. During his 2021 State of the State speech, and included in his budget proposal, the governor promised to introduce legislative reforms intended to strengthen disciplinary actions for professional misconduct, improve enforcement and increase patient safety. One proposed reform is to add transparency by making misconduct investigations and information about non-disciplinary actions available to the public. New York law currently prohibits public confirmation of an investigation. The MSSNY has expressed its opposition to changing the law.

According to Litvack’s communication with members, the MSSNY is “perplexed by proposals to eliminate important due process protections for physicians against whom a complaint has been filed with the Office of Professional Medical Conduct. While we are committed to working to identify gaps in the NYS disciplinary, this budget proposal would give the Commissioner of Health the authority in their sole discretion to disclose to the public that a complaint has been filed against a particular physician, despite the fact that very few complaints ever actually result in a finding of professional misconduct.

“This information can remain on the internet forever, potentially ruining a physician’s professional reputation. The law already permits the commissioner to disclose information to the public when there is a public health threat. This provision would eliminate important due process protections.”

This article originally appeared in Medical Liability Monitor.

Curi logo

Curi Announces Next Chief Executive, Retirement of Current CEO

Medical malpractice insurer Curi recently announced that Jason Sandner will take over as its next chief executive officer on July 1, 2021, when current CEO Dale Jenkins steps down after more than 25 years of service to the company. Sandner is currently the company’s chief operating officer and chief financial officer. Jenkins will continue to serve on Curi’s board of directors after his retirement.

“We believe Jason Sandner will help the company deliver ever-greater success to our member community,” said Robert Schaaf, MD, chairperson of Curi’s board of directors. “We looked for someone who has a passion for serving doctors and believes in the vision and strategy we’re aggressively pursuing. Jason is an extremely capable leader, and our search process proved to us that he is the very best person to lead Curi into the future.” 

Sandner was chosen to succeed Jenkins following a multi-month nationwide search led by Curi’s board of directors with the assistance of executive search firm Heidrick & Struggles. A senior executive with two decades of financial, operational and managerial expertise, Sandner has directed the financial strategy of Curi and its affiliates — including its insurance and investment operations — for more than a decade and was part of the team that oversaw its reorganization as a mutual insurance holding company, its expansion into a number of new states and the diversification of its product offerings outside of the medical professional liability space.

“When I started here at Curi almost 10 years ago, one of the first major initiatives I was a part of was the reorganization and restructuring of the corporation into the mutual insurance holding company that exists today,” Sandner said. “When we were at the front end of that restructuring, the long-range vision was that the restructured format would give us the opportunity to diversify, as we have done during the last eight years.”

Looking toward the future, Sandner sees opportunity in the current hardening of the medical professional liability insurance market.

“Growing in the soft environment we’re coming out of was difficult because there really was no price [insurers weren’t] willing to go to. Retention was incredibly high and dislocating business was very difficult. But this new market — with claims costs accelerating and rate pressures as they are — is creating some disruption and dislocation. It’s giving practices reason to question whether they’re with the right carrier and opening the opportunity for us to tell our value story. I see an opportunity to grow in a disciplined, measured way.”

Provided by Michael Matray of the Medical Liability Monitor

PRI Launches New Admitted MPL Insurer EmPRO in New York

Physicians’ Reciprocal Insurers (PRI) launched EmPRO Insurance Co., a new subsidiary insurer domiciled and authorized to write medical professional liability business in the State of New York, on September 15.

Wholly-owned by PRI, EmPRO is administered by PRIMMA LLC, PRI’s attorney-in-fact. Current PRI insureds will be transitioned to EmPRO when their policies renew without any interruption in coverage, and all new policies will be written through EmPRO.

When PRIMMA took over as attorney-in-fact for PRI on July 1, 2017, the insurer had a negative $341 million surplus. Since that date, PRI has posted an overall surplus improvement of more than $256 million to negative $84.8 million at the end of the second-quarter 2020.

“We’ve seen a continued, quarter-by-quarter surplus improvement driven by a renewed focus on underwriting, which has dropped our loss ratio from the mid-80s to the mid-60s, across all lines,” said Bruce Shulan, PRI vice chairman, president and chief executive officer. “Despite that improvement, reaching new business has been difficult due to the anti-competitive effect of PRI’s insolvency.

“Notwithstanding the protection from state legislation, our insolvency continued to be a barrier. We set out to address that with a plan to set up a subsidiary to PRI, a solvent stock insurance subsidiary, and move PRI’s business into the stock insurance subsidiary so that when we’re selling new business, new policies, we would no longer be under that taint of insolvency.”

In executing that plan, PRI acquired Empire Insurance Co. via a shell company transaction, renamed and rebranded it, and infused the new entity with $100 million of its approximately $900 million in assets.

“EmPRO, on a standalone basis, has $100 million of surplus, wholly-owned by PRI,” said Brian Nolan, PRI executive vice president. “The infusion is reflected on the PRI balance sheet as a $100 million investment in a subsidiary. While PRI may be insolvent, we maintained enough liquidity in our balance sheet for the EmPRO transaction.”

As its attorney-in-fact, PRIMMA will run-off all PRI legacy claims as well as manage the EmPRO business. EmPRO profits will be ceded to PRI until it reaches solvency. PRI will still exist, and all EmPRO policyholders will be subscribers of the PRI insurance reciprocal.

“Any suggestion we’re trying to favor EmPRO to the detriment of PRI is absolutely incorrect,” Shulan said. “This is PRI putting up the capital, and this is PRI absolutely getting the benefit of EmPRO. And because the business mix, operations, technology and people are all the same, the only real difference between PRI and EmPRO is the ability to issue a policy out of a solvent company rather than an insolvent one.”

According to PRI, the move has already attracted the attention of the New York medical professional liability community.

“We’ve received a number of calls from brokers we haven’t worked with in the past,” Nolan said. “They’re trying to get a sense of what we’re all about on a go-forward basis. Naturally, moving from an insolvent company to a solvent one makes it much easier for brokers to market and sell our products.”

“The market is going to notice the solvency, not necessarily where we came from,” added Shulan. “But our view is that where we came from is an important part of the story. It’s been very exciting, and frankly, very unique. I dare say that nobody can point to another insurance company in the United States that started out in the position we were in when we took over at PRI and has traveled this kind of distance at this kind of speed.”

This article was written by Michael Matray, the Editor of Medical Liability Monitor.

If you are looking to get a quote from PRI/EmPRO and the other major medical malpractice insurance carriers in New York, click here.

New York State

New York Gov. Andrew Cuomo Proposes New Physician Oversight Rules

New York Gov. Andrew Cuomo last month announced a proposal for strengthening the oversight of physicians and other medical professionals to better protect patients as part of his State of the State agenda.

Cuomo proposed a comprehensive set of reforms to ensure that the Department of Health’s Office of Professional Medical Conduct has adequate and effective tools to investigate, discipline and monitor physicians, physician assistants and specialist assistants licensed in New York, which he says will provide greater transparency in physician discipline and reduce the length of misconduct investigations.

“The first responsibility of any medical professional is do no harm, and when someone violates that oath, they must be held appropriately accountable,” Cuomo said. “These sweeping proposals will help ensure patients have access to critical information they need to make informed decisions about their healthcare and give state health regulators more tools to investigate and penalize providers for dangerous, unethical or illegal behavior.”

Under current New York law, the Department of Health is prohibited from confirming the presence or absence of an investigation. The Cuomo administration believes healthcare consumers and patients deserve access to this information, when the commissioner of health deems it’s warranted. Additionally, certain “expedited processes” exist in the law, wherein a physician may be issued a warning for a minor and technical violation, which does not rise to the level of prosecutable misconduct. These warnings are, under current law, non-disciplinary and non-public, but will now be made publicly available.

Eliminating Lifetime Licensure

Under current law, physicians, physician assistants and specialist assistants licensed in New York remain licensed for life unless some action is taken against their licenses, even if they move out of state. The governor’s proposal would require doctors to periodically renew their New York State Medical Licenses or lose them, along with the ability to practice medicine in New York.

Additionally, the Office of Professional Medical Conduct (OPMC) would be required to investigate every New York state licensee charged with misconduct in another state, but in many cases, those licensees have not practiced medicine in New York in several years, if ever. If doctors practicing outside the state could place their New York licenses in an inactive status, it would allow OPMC to dedicate its resources to investigating complaints against licensees who are practicing here.

Reform Public Health Law Provisions

To strengthen public safety, Cuomo proposes updating the public health law to allow the state health commissioner to summarily suspend a physician’s license at the start of an investigation if the commissioner deems that physician a risk to the public. Current law requires a physician to be an imminent danger before their license can be suspended.

According to the Cuomo administration, physicians have many due process procedural rights under current state law that impede and greatly lengthen the progress of an investigation and disciplinary finding. In 2018, the average amount of time to close a full OPMC field investigation was 307 days. These permitted delays allow physicians who are potentially bad actors to continue practicing medicine at patients’ risk. Thus, the governor believes that the health commissioner and OPMC must have the authority and tools necessary to act to protect the public.

Ensure Consumers Have Up-To-Date, Accessible Information About Physicians

The Physician Profile is a publicly available, online resource providing information about individual New York state licensed physicians, including medical education, translation services at the doctor’s office and information about legal actions taken against the doctor.

However, other important information, such as insurance network participation, practice location, hours of operation and whether the office is accepting new patients, are currently either optional or not required under the public health law. To help ensure consumers can make informed decisions about their healthcare, the Cuomo administration intends to introduce legislation to ensure the public can access this critical information.

Doctors Have Concern Over Due Process

In response to the governor’s proposal, the Medical Society of the State of New York voiced concern that the proposal fails to strike a balance between improving public safety and protecting against the consequences of unfounded allegations against medical workers.

“We are extremely concerned about the scope of the proposals that would essentially strip physicians of important due process rights when a complaint has been filed with the Office of Professional Medical Conduct,” said Art Fougner, MD, Medical Society of the State of New York president, in a statement. “We agree with the importance of acting quickly when it is imperative, but these proposals would completely undermine important and longstanding due process protections. Given that most complaints are dismissed without any sanction or action, this series of proposed changes to bypass these rights would create a substantial possibility of unfairly destroying an innocent physician’s career.

“Due to our enormous liability costs and excessive regulations, New York already has the dubious reputation of being the worst state in the country to be a physician. Proposals like this will make it even more unattractive for physicians to choose New York to deliver patient care.”

Why Do I Need a Medical Malpractice Insurance Broker When Seeking Medical Director Insurance?

I recently had a lengthy discussion with a general surgeon from New Jersey, who was offered a medical directorship at a surgical center in Manhattan, N.Y. He explained that the surgical center would not provide his medical malpractice insurance and, therefore, would need to secure his own coverage. When he called his current insurer, they explained that they do not cover medical director exposures. Calling around to other medical malpractice insurance companies in New York, he received the same news. Frustrated, the doctor called me saying he couldn’t even get anyone to steer him in the right direction for acquiring medical director insurance.

This was my jumping off point for explaining the differences between the two predominate types of medical malpractice insurance companies and the value of working with a medical malpractice insurance broker. First, there are the “admitted” companies. These are the companies that focus their attention on traditional doctors and their practices. They do not provide coverage to physicians who have lost big verdicts or large number of malpractice claims, gaps in coverage or licensing issues. They also do not provide coverage to facilities and organizations, like locum’s tenens companies, medi spas, medical directors and other types of medical practices that are outside of a traditional physician practice. These admitted companies are licensed by the states in which they operate and file their rates and guidelines with those states’ Departments of Insurance. As such, these admitted insurance companies must be very strict in what they can and cannot cover because they must abide by their filed guidelines.

Physicians who — for whatever reason — cannot secure medical malpractice insurance on the admitted market, purchase their coverage from “surplus lines” insurance companies. These companies are not licensed by the state, so they are not required to file their rates and guidelines, which affords them more leeway in determining what and who they will and will not insure. These companies must be approved to do business within the state, but are designed with more latitude in order to offer coverage to physicians when the admitted companies cannot.

I explained that we would approach all of the companies who specialize in offering medical director insurance so that we could flush out the most competitive offers as well as the best policy terms.

After completing various, specific medical director insurance applications, we secured five different quotes for him. After another discussion about which company would be the best fit for him, we secured the policy of his choice. He not only continues to work at the surgical center, but has picked up two more medical directorships at separate locations — all covered under the medical director insurance policy we acquired together.

Without the knowledge, experience and access that comes from working with an experienced medical malpractice insurance broker, our general surgeon wouldn’t have been able to navigate the tricky world of medical malpractice insurance companies in New York to find his medical director insurance.

Are you looking for medical malpractice insurance in New Jersey, New York or any other state? Call me at 708-848-2300 to discuss your options.

MLMIC Completes Demutualization, Acquisition by Berkshire Hathaway

MLMIC Insurance Co. announced last month the completion of its conversion from a property-and-casualty mutual insurance company to a property-and-casualty stock insurance company and the finalization of its $2.5 billion acquisition by National Indemnity Co., a subsidiary of Berkshire Hathaway Inc.

The conversion and acquisition followed a September 6 approval by the Superintendent of the New York State Department of Financial Services and a September 14 vote of MLMIC policyholders with policies in effect on July 14, 2016. The cash consideration resulting from the conversion will be paid out to eligible policyholders — policyholders with policies in effect from July 15, 2013, through July 14, 2016 — or their designees as promptly as practicable, according to the company.

As a subsidiary of Berkshire Hathaway, MLMIC will have enhanced capacity and financial strength to continue serving New York State physicians, hospitals and dentists. MLMIC remains the largest underwriter of medical professional liability insurance in New York and continues to be a New York‐focused medical malpractice writer regulated by New York State. The same Board of Directors and staff that have served the market for several decades will operate it.

“No one will see any difference [in day-to-day operations],” said Berkshire Hathaway chief executive Warren Buffett, during a livestreamed conversation between himself and James Reed, MD, MLMIC chairman of the board, from Berkshire Hathaway’s Omaha, Neb., headquarters on October 17. “The one thing that we will do is manage [MLMIC’s] investments.”

Reed highlighted how Berkshire Hathaway’s deep resources position MLMIC to address the challenging risks of the New York market as well as the hyper-evolving American healthcare delivery system.

“The tremendous financial resources of Berkshire Hathaway [lets us] assure physicians in New York that if they’re insured with MLMIC, there’s nothing that could come at us that we wouldn’t have the resources to deal with,” he said. “And the resources will allow us to be much more innovative in the way we approach malpractice insurance in the future.”

Reed pointed to the consolidation within the healthcare delivery system as one of the particularly pressing challenges currently facing the medical professional liability insurance industry that MLMIC wants to proactively address.

“At MLMIC, we know we’re going to have to be innovative with the consolidation that’s occurring — physicians coming together to form larger groups, health systems coming together, large groups coming together with health systems,” Reed said. “We need to be more innovative on the medical malpractice insurance side, and that’s exactly what we want to do as part of Berkshire Hathaway with those resources. We have a number of innovative ideas [for working] with some of these larger groups [that] we just couldn’t do in the past.”

In addition to National Indemnity Co. and MLMIC, Berkshire Hathaway also owns MedPro Group, which provides medical professional liability coverage in New York through its subsidiary risk retention group, MedPro RRG. And both Buffett and Reed view the intra-company competition as a benefit.

“We like the competition,” Buffett said. “For example, in workers compensation insurance, we have three different [companies] that have somewhat different areas of expertise. We have totally independent organizations that are out there calling on the same firms, trying to get their worker’s compensation business. Competition is fine.”

“We’re also hoping to be able to collaborate [with other Berkshire Hathaway companies operating in medical liability] because one option to consolidation in healthcare is collaboration,” Reed said. “The difficulty in doing that is always a legal one, but by being part of a single company like Berkshire Hathaway, we think particularly in the areas of working on patient safety, analytics and so forth, we can collaborate some. While each company pursues its own direction, some of those things that are common across the malpractice insurers within Berkshire Hathaway, we will be able to bring together and leverage that kind of capability to improve patient safety and, therefore, better outcomes from the malpractice standpoint.”

This information provided by Michael Matray of the Medical Liability Monitor.

New York’s Medical Malpractice Market in the Spotlight

by Michael Matray, editor of Medical Liability Monitor

New York’s medical malpractice insurance market was the subject of two lengthy articles last month that examined the state’s shifting competitive landscape and the questionable finances of its second-largest insurer of medical liability, Physicians’ Reciprocal Insurers (PRI).

In an article dated April 9, Politico New York primarily concentrated on the influx of risk retention groups (RRGs) to the New York market and its effect on the state’s admitted medical professional liability insurance companies. RRGs are governed by the federal Liability Risk Retention Act of 1981, which allows persons engaged in similar activities to band together as a self insurer to cover each other’s risks. The entity is only governed by the laws of the state in which it is domiciled, but free to offer coverage in all other states. Admitted insurers have been approved by the state’s insurance department, must comply with all state regulations, and in the event of financial failure, the state’s medical malpractice guaranty fund will cover its losses. The guaranty fund is a safety net financed by the state’s other admitted insurers. If an admitted insurance company fails, the costs are passed to the state’s other admitted insurers.

The Politico New York article noted that New York has 63 medical malpractice RRGs, 16 of which have entered the market since 2012. Because these RRGs are not required to pay into the state’s guaranty fund, they are often able to offer premiums that fall well below the state’s admitted insurers.

The less-expensive rates many RRGs are offering have affected the net written premium of the state’s two largest admitted insurers of medical liability, Medical Liability Malpractice Insurance Co. (MLMIC) and PRI. According to the Politico New York article, MLMIC’s net written premium decreased $79 million between 2014 and 2015, while PRI’s net written premium fell by $90 million. MLMIC remains financially strong with $1.8 billion in surplus, but as Politico New York points out, PRI reported a net underwriting loss of $12 million in 2015 and a $25 million loss in 2014. PRI’s liabilities exceed its assets by more than $138 million.

Because the New York Department of Financial Services has no control over the capital reserve requirements of RRGs operating in the state, and RRGs have the option to exit the market whenever they see fit, some legislators and regulators have expressed concern with their growing influence over the New York medical malpractice insurance market. “I know [an RRG] is a lower-cost option but I would say it is a riskier option,” Politico New York quoted state Sen. James Seward, who chairs the chamber’s insurance committee, as saying.

In an article also dated April 9, the Albany Times Union focused exclusively on the concerning financials of PRI and the role of Anthony Bonomo, the chief executive officer of Administrators for the Professions (AFP), Inc., which manages administrative and claims services for PRI. The reciprocal insurer has no actual employees and is operated by AFP, which collects a $42 million management fee from PRI. The article also noted that PRI’s 2015 expense ratio was 19 percent, more than double that of MLMIC.

In addition to chronicling PRI’s underwriting losses and negative surplus, the Times Union article delved into Bonomo’s role in events underlying the 2015 corruption trial of ex-Senate majority leader Dean Skelos.

In 1985, the state legislature enacted a law that allows medical professional liability insurers to operate at a loss. The law’s continued renewal is critical to PRI’s ability to operate, and the reciprocal spends considerable lobbying dollars to ensure that it does. Prior to his arrest in May of last year, Skelos was influential in passing the law’s most recent renewal, good through 2019.

The U.S. Attorney’s Office charged Skelos with extorting those with business before New York State to make payments to his son Adam with the expectation that such payments would result in official action by Skelos. According to prosecutors, Skelos pressured PRI to hire his son in 2012 for what turned out to be a no-show job. Skelos and his son were convicted in December of eight federal bribery, extortion and conspiracy counts involving PRI and two other companies. Bonomo was a witness for the prosecution, testifying under a non-prosecution agreement.

The Department for Financial Services declined a Times Union open records request for its three most recent financial examinations of PRI, saying the exams were never formally adopted and filed, and therefore not public.

Both the Times Union and Politico New York articles mentioned the unconfirmed industry rumor that AFP has been in ongoing discussions with The Doctors Company to sell its assets to the California-headquartered insurer of medical liability. [Editor’s note: On May 2, Politico New York published an article that reports The Doctors Company has withdrawn its offer to purchase AFP.]

New York Med Mal Coverage

Today we are writing about New York med mal coverage and risk retention groups (RRGs). Whenever a physician asks us what are the best and worst states to practice in from a med mal coverage standpoint, we always have to mention New York as the later. Unfortunately for physicians and caregivers in New York, New York med mal coverage remains some of the most expensive and the choices remain limited.

So what are your New York med mal coverage options? As we stated, they are limited. As far as admitted carriers go, there are only two options: PRI and MLMIC. For physicians looking for price relief, or who are not being accepted by PRI or MLMIC, there are about 5 or 6 risk retention groups (RRGs) that provide excellent coverage and policy features.

Physicians Talking One of the first things that we have to do as New York med mal agents is to identify the doctor’s situation and where they are practicing. For instance, a doctor practicing in Manhattan or New York City with privileges at one of the major hospitals, usually only has a choice between PRI and MLMIC. If a physician needs to seek coverage from an RRG, many times we find ourselves calling a hospital’s credentialing or risk management department to make sure that they accept coverage from the companies we are seeking. It is impossible to underestimate the importance that the hospital accepts coverage from the RRGs, because most do not in Manhattan.

New companies entering New York as RRGs. Several years ago, now Governor Andrew Cuomo approached the various national medical malpractice insurance companies and asked them to consider entering the state to provide New York med mal coverage. While most companies declined to enter the state on an admitted basis, they were willing to come in structured as RRGs, and therefore, would not participate in the state’s Department of Financial Services guarantee fund. For instance, Medical Protective, the Berkshire Hathaway company, entered the state structured as an RRG and now offers coverage to doctors under an excellent, A-rated Med Pro policy.

If you take away on thing from this article, please note that while your options may be limited, the agents at MyMedicalMalpracticeInsurance.com have the expertise and reach to makes sure that all of your options are laid out in from of you. Don’t hesitate to contact us today.

Flashback: New York Malpractice Insurance Gets First Rate Increase After Two-Year Moratorium

side note: This article first appeared in the August 2010 issue of Medical Liability Monitor, the industry’s premier source for consistent, reliable coverage and fresh perspectives on medical professional liability insurance and risk management issues. To subscribe to the Monitor, please click here.

On July 6, 2010, Insurance Superintendent James J. Wrynn announced the approval of a five-percent average New York malpractice insurance rate increase for the state’s doctors. By New York law, Wrynn is charged with establishing the rates for medical malpractice insurance coverage. The increase, which took effect retroactively to July 1, followed a two-year moratorium on malpractice rate increases.

“I am pleased that we could keep the first medical malpractice rate increase in three years to an average of five percent,” Wrynn said. “This rate will help hold the line on costs for physicians while giving the insurance companies the resources to pay claims as they come due.”

Wrynn established new base rates resulting in five percent increases for Medical Liability Mutual Insurance Company (MLMIC), the largest medical malpractice insurer with almost 60 percent of the market, and Physicians’ Reciprocal Insurers (PRI), the second largest medical malpractice carrier with almost 30 percent of the market. Two smaller specialty carriers, Hospitals Insurance Company (HIC) and Academic Health Professionals Insurance Association (Academic), also received five-percent increases. While the average rate will increase by five percent, some doctors’ increases can be somewhat more or less depending on their specialty and location.

The Medical Malpractice Insurance Pool (MMIP) is the state’s insurer of last resort. MMIP provides insurance for doctors and others who are not able to get insurance in the voluntary market. For the fewer than 300 doctors covered by the pool, rates will rise an average of 9.9 percent. The Department of Insurance does not set rates for risk retention groups and captives.

“In the short term, this increase will relieve the pressures on both doctors and insurers,” Wrynn said. “But long term, the system is still in crisis and needs to be reformed. We cannot afford to lose doctors because of high medical malpractice insurance rates and we have to make sure patients are properly protected. We will keep working toward a longterm solution.”

Industry insiders have noted for years that New York has had a dwindling number of medical liability insurers because there exists the perception that the state does not allow them to charge sufficient rates. In addition, the MMIP, which is funded chiefly by the insurers licensed in the state, is running a deficit of almost $500 million.

“Ever since 2001, the severity of claims costs for all New York physicians has been increasing significantly; however, the rate increases set by the Superinten-dent of Insurance have not kept pace,” wrote Robert A. Menotti, MD, MLMIC president, in a letter to policyholders after last year’s continued rate freeze. “MLMIC has had to absorb this difference by a reduction in our surplus funds. Our company’s surplus is comprised of funds (held in excess of the reserves set aside to pay claims) which are maintained for unforeseen events, such as catastrophic losses.”

Earlier this year, Wrynn proposed the creation of an independent rate service organization to attract medical malpractice insurers to the New York market and all property/casualty insurers agreed to an assessment plan to reduce the $480 million deficit in New York’s Medical Malpractice Insurance Plan.

Recent Changes to the New York Med Mal Ins Market

Thermometer and PillsAlthough it’s one of the largest states from the med mal ins premium point of view, New York can be a very frustrating state when looking for med mal ins. Doctors have limited choices for New York med mal ins and the state needs to see some reform in order to have a more competitive environment. But, we are hopeful for the future for a couple of reasons that we will discuss later in this post.

The two main admitted carriers (See our Med Mal Ins Q & A page for our glossary of terms) in New York state are PRI and MLMIC. (Most states’ physicians will have access to 10 or more admitted carriers.) Because of the quirkiness of New York state overall, the only other type of med mal ins carriers are risk retention groups (RRGs). The RRGs play an important role in creating a competitive market and offering an alternative to physicians. Although the RRGs are not admitted, and considered a surplus, or non-admitted carrier, they still offer an excellent alternative and should not be dismissed or overlooked. It’s important to note that most major New York City-based hospitals do not accept coverage by RRGs. Before you shop for coverage with risk retention groups, you should contact your hospital’s risk management or credentialing groups to see if they accept risk retention group coverage.

But, there’s some good news. The outlook for the future is encouraging. For instance, Med Pro, from Berkshire Hathaway, has entered the state in the form of its own RRG. Because the Med Pro policies are written on Med Pro paper, this means that physicians have the backing of a company with over $60 billion in cash. Med Pro was unwilling to enter New York state as an admitted company but was willing to enter the state as an RRG. And, in the past week, we have learned that another major national med mal ins carrier, Coverys, is also in the process of setting up an RRG in New York state and we think that other major carriers are not far behind.

Because the market is always changing, if you are a New York physician, it’s always important to shop for coverage every year. Contact us today.